# persona_off · bixbench · bix-53-q6

[All trial-1 traces](../../README.md)

- Trial: **1**; endpoint: **original_fallback**; attempt: **1**.
- Native status: **missing_submission**; normalized native score: **0/100**.
- Recorded protocol: `researcher-review-v2`.
- Actor, simulator, and judge: **GPT-6 Astra, low reasoning**.
- Scope: chronological shared messages and handoff fields. Private tool logs, system prompts, evaluator references, and raw API requests are not included.
- A repaired endpoint belongs to the same trial; it is not an independent repeat. Zero scores and missing scientific submissions are retained.

## Shared conversation

### Event 1 — Simulator

**Message**

````text
Inspect data/count.csv and any accompanying repository metadata only; do not run the full analysis yet. Report the count matrix dimensions, gene identifier type, count validity, sample labels, and any evidence establishing which samples are UBE2M KD versus control. The supplied schema lists geneID, KL1–KL3, and WL1–WL3; do not treat the group meanings as established from labels alone. Propose an executable differential-expression and log2 fold-change shrinkage approach, followed by GSEApy enrichment using KEGG_2019_Mouse. Explain how you would apply p-value <0.05, absolute shrunken log2 fold change >1, and baseMean >10, handle gene identifiers and enrichment background, and define the most significantly enriched pathway. Identify consequential assumptions and available tooling/library access. Return inspection findings and the proposed approach for review, not a pathway result.
````

**Interaction**

````text
initial_request
````

**Phase**

````text
initial_inspection
````

**Action**

````text
continue
````

**Approve Approach**

````text
false
````

**Evidence**

````text
The supplied context identifies data/count.csv and its header, but group assignments, identifier type, count suitability, and analysis tooling have not yet been inspected.
````

**Objectives Open**

````text
[
  "Inspect inputs and establish sample-group evidence and gene identifiers.",
  "Review an executable differential-expression, shrinkage, and KEGG_2019_Mouse enrichment approach.",
  "Execute the approved analysis and retain its script or notebook.",
  "Report the most significantly enriched pathway with execution status and artifact path."
]
````

### Event 8 — Actor

**Answer**

````text
Inspection only completed; no differential expression, shrinkage, or enrichment was run.

Findings
- data/count.csv has 21,884 rows × 7 columns: geneID plus six count columns (21,884 genes × 6 samples).
- All 21,884 gene IDs are unique, unversioned mouse Ensembl gene identifiers matching ENSMUSG followed by digits; no missing identifiers.
- Samples are KL1, KL2, KL3, WL1, WL2, WL3. Counts are finite, nonnegative integers with no missing values, range 0–614,374. There are 5,984 all-zero genes and 15,900 genes with at least one count.
- Library totals: KL1 19,081,441; KL2 19,277,411; KL3 18,407,120; WL1 19,029,638; WL2 20,030,776; WL3 17,910,706.
- The only accompanying file is task.json. It restates the question and lists the count input, but provides no sample-to-condition key, batch, pairing, or biological-replicate information. There is no evidence establishing KL as KD or WL as control (or the reverse). Labels alone are insufficient.

Proposed executable approach, subject to approval and dependency access
1. Fit a two-group negative-binomial model using PyDESeq2 with design ~group, median-of-ratios size factors, dispersion estimation, and Wald testing. Remove only all-zero genes initially; retain the low-count genes for fitting and apply the requested baseMean filter afterward. Treat the three samples in each prefix group as independent replicates, unless metadata establishes otherwise. Use explicit KL-versus-WL contrast until a sample key establishes KD-versus-control; reference coding will be recorded.
2. Use PyDESeq2's supported apeGLM-style LFC shrinkage on the single group coefficient (lfc_shrink with the model coefficient), keeping the original Wald p-values. Select genes using strict raw p-value <0.05, absolute shrunken log2FC >1, and baseMean >10. baseMean is the mean normalized count across all six samples. Do not substitute adjusted p-values for the requested raw p-values. Exclude nonfinite statistics and report exclusions.
3. Map mouse Ensembl IDs to official mouse gene symbols using a saved, versioned annotation source compatible with the KEGG library. Remove version suffixes if encountered (none currently present); report mapping coverage and unresolved/ambiguous mappings. Exclude ambiguous one-to-many mappings rather than expanding one gene into multiple symbols; deduplicate many-to-one symbols after selection. Apply exactly the same mapping rules to foreground and background.
4. Retrieve and cache the exact KEGG_2019_Mouse gene-set library using GSEApy. Use GSEApy enrichr locally with that library dictionary and an explicit background: unique mapped symbols from genes with finite test results and baseMean >10, i.e. genes eligible for selection before applying p-value and effect-size thresholds. This avoids assuming all mouse genes were assay-detectable. Record the effective background used by GSEApy and any genes lacking KEGG annotation. Use the combined up/down significant-gene list, consistent with the absolute-fold-change criterion; this is overrepresentation enrichment, not ranked-list GSEA.
5. Define 'most significantly enriched' as the pathway with the smallest enrichment raw p-value; compute/report BH-adjusted enrichment p-values, overlap, and contributing genes as well. Do not rank by combined score. Report ties if present and avoid claiming statistically significant enrichment if no pathway passes enrichment FDR <0.05. Because background choice can change the answer, also check the conventional Enrichr library-background ranking as a clearly labeled sensitivity analysis, without replacing the primary explicit-background result.
6. Save the complete executed analysis script, parameter/version records, mapping diagnostics, DE table, selected genes, and enrichment table. The final result handoff will include artifacts.analysis and executed_analysis=true only after actual execution.

Consequential choices and constraints
- Sample identity remains unverified. A two-group combined up/down analysis does not depend biologically on which group is called KD, but signed effects and claims about KD direction require a sample key. Reversing a simple two-group contrast should preserve the absolute-effect selection; any numerical shrinkage sensitivity can be checked.
- No evidence supports paired or batch-adjusted modeling. Independent replicate assumptions and the eligible-gene enrichment background need approval.
- Tooling is currently a blocker: Python 3.12.11, pandas, NumPy, and SciPy are available; PyDESeq2, GSEApy, anndata, mygene, requests, pip, and Rscript are absent. Direct probes of PyPI and the KEGG_2019_Mouse Enrichr endpoint failed with DNS resolution errors. No annotation or gene-set files are supplied. Execution therefore requires provisioning PyDESeq2/GSEApy and their dependencies plus a mouse annotation and the exact library, or enabling package/network access. I would not replace the mandated GSEApy/library or fabricate results.

Please approve the approach and provide/provision dependency and annotation/library access; provide a sample key if available. No pathway result is proposed.
````

**Stage**

````text
plan
````

**Evidence**

````text
Workspace inventory: only ./data/count.csv and ./task.json. pandas inspection: shape=(21884,7), duplicated geneID=0, all columns missing=0, all count values finite/nonnegative/integer, zero-count rows=5984, ENSMUSG-format fraction=1.0. Dependency checks found no PyDESeq2/GSEApy/Rscript/pip. urllib probes to pypi.org and maayanlab.cloud returned Temporary failure in name resolution.
````

**Assumptions**

````text
[
  "KL and WL define the two comparison groups, but neither group's treatment meaning is established.",
  "Samples are independent replicates and no batch/pairing covariate is available.",
  "Primary enrichment uses mapped, tested genes with baseMean >10 as the eligible background; raw enrichment p-value defines the top pathway."
]
````

**Uncertainties**

````text
[
  "KD/control mapping and replicate provenance are absent from supplied metadata.",
  "Packages, exact KEGG library, and versioned mouse annotation need provisioning; network probes currently fail.",
  "Annotation mapping and enrichment-background choice may change the leading pathway."
]
````

### Event 9 — Simulator

**Message**

````text
I approve the proposed analysis, including the independent two-group model, shrinkage before absolute-effect filtering, raw differential-expression p-values, combined up/down foreground, and explicit eligible-gene background. Treat sample identity and replicate independence as assumptions, not established metadata; I have no sample key or provisioning capability to supply. Report the conventional Enrichr-background sensitivity alongside the primary result if its leading pathway differs. Use enrichment p-value ranking and report FDR without conflating a leading pathway with significant enrichment.

Proceed with execution if dependencies and data resources can be obtained. First check available runner environments, cached packages/resources, and supported installation/bootstrap options; retry network access if appropriate. Do not replace GSEApy, the exact KEGG_2019_Mouse library, or genuine LFC shrinkage with approximations. Record annotation provenance and effective enrichment background. If access remains blocked after focused checks, report the concrete blocker honestly rather than inventing a pathway or claiming execution. Retain the analysis script at a reported path, clearly distinguishing any unexecuted portions. The final submission should include a concise answer, payload.executed_analysis set true only after executing the analysis, and artifacts.analysis pointing to the retained script or notebook. If execution succeeds, include filter counts, mapping coverage, shrinkage diagnostics, and the leading enrichment result as supporting evidence.
````

**Interaction**

````text
next_task
````

**Phase**

````text
approach_review
````

**Action**

````text
continue
````

**Approve Approach**

````text
true
````

**Evidence**

````text
Inspection reports a valid 21,884-gene six-sample mouse count matrix, with no sample key. The proposed method implements all specified filters and shrinkage and reasonably addresses identifier mapping and background ambiguity. Execution is currently blocked by missing required tools and failed resource access; no analysis results have been reported.
````

**Objectives Open**

````text
[
  "Obtain required execution dependencies, mouse annotation, and exact KEGG_2019_Mouse library or document the persistent access blocker.",
  "Execute the approved differential-expression, shrinkage, filtering, and GSEApy enrichment workflow.",
  "Report the leading pathway with supporting diagnostics and retain the analysis artifact in the required submission format."
]
````

### Event 18 — Actor

**Answer**

````text
The most significantly enriched pathway could not be determined: required PyDESeq2/GSEApy packages, the exact KEGG_2019_Mouse library, and mouse annotation could not be obtained in this runner. No differential-expression, LFC-shrinkage, or enrichment analysis was executed, and no pathway result is claimed.

The retained analysis.py was executed for count inspection and resource preflight only. Its docstring records the approved downstream workflow explicitly as unexecuted and not implemented. payload.executed_analysis remains false.
````

**Stage**

````text
result
````

**Evidence**

````text
Focused checks found the actor Python environment and a system Python with pip 24.0; ensurepip bootstrap support is also present. This corrects the initial broader impression that no installation tool was available: pip is absent from the actor interpreter but exists under /usr/bin. Neither environment has GSEApy or PyDESeq2; Rscript is absent. Searches of visible home/net environments found no GSEApy, DESeq, or KEGG resources. pip cache reports zero HTTP files and zero wheels. A real `pip install --target /workspace/vendor --retries 1 --timeout 10 pydeseq2 gseapy` attempt failed because /etc/ssl/certs/ca-certificates.crt is unavailable. Independently, repeated urllib probes to PyPI, the exact KEGG_2019_Mouse Enrichr endpoint, and Ensembl all failed with DNS resolution errors; /etc/resolv.conf is absent. No network-security checks were bypassed.

Executed script confirms 21,884 unique unversioned mouse Ensembl genes × 6 samples (KL1–KL3, WL1–WL3), no missing/negative/noninteger/nonfinite counts, and 5,984 all-zero genes. Only count.csv and task.json were supplied; neither establishes KD/control identity. The script and JSON preflight evidence were written successfully. There are no DE filter counts, mapping coverage, shrinkage diagnostics, effective enrichment background, enrichment p-values/FDR, or background-sensitivity results because those operations were not executed.
````

**Assumptions**

````text
[
  "KL/WL form an independent two-group comparison only as an approved modeling assumption.",
  "KD/control identities and replicate independence remain unverified.",
  "Approved downstream methods remain unchanged; no approximate replacement for GSEApy, the exact library, or genuine shrinkage was used."
]
````

**Uncertainties**

````text
[
  "No supported evidence identifies any leading pathway.",
  "Execution requires accessible package dependencies, the exact gene-set resource, and a provenance-recorded mouse annotation; provisioning remains unavailable."
]
````

### Event 19 — Simulator

**Message**

````text
Conclude with the reported inability to determine the pathway, retaining payload.executed_analysis=false and artifacts.analysis="analysis.py". Clearly state that the script executed inspection/preflight only, not differential expression, shrinkage, or enrichment. No pathway can be supported by the available evidence; do not imply that the scientific objective was completed.
````

**Interaction**

````text
conclude
````

**Phase**

````text
result_review
````

**Action**

````text
stop
````

**Approve Approach**

````text
false
````

**Evidence**

````text
The handoff reports focused environment/cache checks, an actual failed installation attempt, and repeated DNS failures for package, annotation, and exact library resources. It retains a script and preflight evidence and makes no unsupported pathway claim. Required scientific analyses remain unexecuted; further requests without changed resource access would not resolve the blocker.
````

**Objectives Open**

````text
[
  "Execute differential expression and genuine log2 fold-change shrinkage with the specified gene filters.",
  "Run GSEApy enrichment with KEGG_2019_Mouse and identify the leading pathway."
]
````

### Event 20 — Controller termination

**Reason**

````text
No complete, researcher-reviewed final candidate at termination
````

## Provenance

````text
{
  "source_run": "runs/openai-astra-top2-first-pass",
  "repair_run": "runs/repair-1-openai-astra-top2-first-pass",
  "event_log": "runs/openai-astra-top2-first-pass/episodes/bixbench_bix-53-q6-d2d7358528e3/persona_off/attempt-1/output/bixbench_bix-53-q6-d2d7358528e3/controller/events.jsonl",
  "event_log_sha256": "e9d4bacb9300b0a1d64a5954d5a4c06b3afbd2ae6896223f96548301bdfb9393",
  "models": {
    "actor": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    },
    "researcher": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    },
    "judge": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    }
  }
}
````
